Onderneming Fluicell AB (publ) Nasdaq Stockholm
Aandelen
SE0010831321
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Single-cell Microfluidic Research Tools and Services
100,0
%
| 3 | 100,0 % | 3 | 100,0 % | +2,68% |
Verkoop per regio
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 3 | 100,0 % | 3 | 100,0 % | +2,68% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Carolina Trkulja
CEO | Chief Executive Officer | 40 | - |
Founder | 44 | 02-01-12 | |
Director of Finance/CFO | 54 | 01-07-23 | |
Jonas Hannestad
IRO | Public Communications Contact | 43 | 01-01-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jan Orwar
BRD | Director/Board Member | 60 | 01-01-15 |
Daniel T. Chiu
BRD | Director/Board Member | 52 | 01-01-17 |
Stefan Tilk
CHM | Chairman | 59 | 01-01-16 |
Founder | 44 | 02-01-12 | |
Carl Fhager
BRD | Director/Board Member | 49 | 01-01-17 |
Regina Danielson
BRD | Director/Board Member | 60 | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 299 402 455 | 293 336 318 ( 97,97 %) | 0 | 97,97 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,63% | 50,93 mld. | |
-0,09% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-4,96% | 29,18 mld. | |
+11,18% | 26,02 mld. | |
-21,95% | 18,9 mld. | |
+8,61% | 13,21 mld. | |
+24,73% | 12,17 mld. | |
+28,31% | 12,16 mld. |